Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis
about
Update in vitamin D and multiple sclerosisVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseStatin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approachThe multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literatureVitamin D and inflammatory diseases.Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.Influence of Diet in Multiple Sclerosis: A Systematic Review.Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways diseaseThe initiation and prevention of multiple sclerosis.Prevention and treatment of MS: studying the effects of vitamin D.Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.Low-dose oral cholecalciferol is associated with higher numbers of Helios(+) and total Tregs than oral calcitriol in renal allograft recipients: an observational studyMapping Variation in Cellular and Transcriptional Response to 1,25-Dihydroxyvitamin D3 in Peripheral Blood Mononuclear Cells.Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.Vitamin D₃ and monomethyl fumarate enhance natural killer cell lysis of dendritic cells and ameliorate the clinical score in mice suffering from experimental autoimmune encephalomyelitis.Calcitriol modulates the CD46 pathway in T cells.Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report.Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisSafety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.Vitamin D in systemic and organ-specific autoimmune diseases.The potential role of epigenetic modifications in the heritability of multiple sclerosis.Role of vitamin D in acquired immune and autoimmune diseases.Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.Controversy and consensus regarding vitamin D: Recent methodological changes and the risks and benefits of vitamin D supplementation.Effects of vitamin D3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.Fat-soluble vitamins as disease modulators in multiple sclerosis.Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.Promoting return of function in multiple sclerosis: An integrated approach.Paradigms in multiple sclerosis: time for a change, time for a unifying concept.Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation.Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.Response to comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'.Daily Cholecalciferol Supplementation during Pregnancy Alters Markers of Regulatory Immunity, Inflammation, and Clinical Outcomes in a Randomized Controlled Trial.
P2860
Q26780466-DB9EE906-A8B4-4B86-9BDD-55F68B11172EQ28081150-212F89B1-3813-4D5F-BD25-85CB431D3952Q28481469-AE9AB19D-9E8C-497E-B5B5-988F91C7FAF2Q30388273-E21AB3DE-4AB3-4131-97B3-F027E16E3CE0Q33592080-F4B9465B-1DA7-4DDB-92EA-B9298BF30B2CQ33806322-012CCB5F-299C-4190-8CDC-E9F2997E7E5DQ34550631-D4A4A484-79CB-40FD-944E-ACF5E69CE6E1Q34681985-71A06A63-C9B5-43D0-BA0A-F42A9D8A9D6FQ35086209-F0BAA804-B1F4-43AB-B708-EF32AC2DECA1Q35741861-FC7BE667-F31E-4359-9447-6082EC6DAB90Q35956133-75353F95-B77A-41C3-8584-0E8D247E0C53Q36045080-27428E76-A996-46F3-97D6-B52A15C0207DQ36050928-55689E20-5B1B-4619-AEB7-A90E626D616EQ36084601-5952851D-761D-4CE7-A354-E4C66A1367D4Q36158139-196D9737-52AA-4753-A1E5-CF3184D48103Q36329622-DD9C20C6-5AB0-433C-A7EA-B7277F51C8C8Q36353718-193D23ED-1A08-4AD5-9DB3-7E78612A0F5AQ36396585-36282AC8-9784-4F25-BDE3-9BBC6286E081Q36638670-D5D26AFE-9C23-4571-B151-A1B84E1E1896Q36645164-4DB0BB86-2190-4426-900F-23B8128B88E0Q36751056-5AC993B0-E861-4D0E-93D3-4E66367BD06FQ37428539-325243A8-886F-4438-9516-13710C09F66AQ38024285-8D61B8ED-41CB-4C00-BD52-EE64B9859A8CQ38067276-FC36802B-4EA0-408F-90C6-E6A7136D1498Q38184977-302AE638-4AE2-4564-8A43-7CC8838DCE62Q38210581-3E6DCC54-4640-47E3-B420-60B4F9748618Q38387302-DE57C988-57CA-479A-BE29-5923F6EBD83FQ38588203-2096ABAD-7FFF-44BE-B8AA-754C2572BA44Q39069015-B9500993-6F65-4B1B-9CB7-A223ABE037EAQ39509517-976B1C19-6F53-4D1D-9E8D-000D35F1895EQ39737347-8F3E2C55-B51A-4240-BF7F-3EE8F50A82F4Q40969344-CE89E05E-05FD-459E-ADF7-78CC21BD7D03Q41872258-8DA52C0C-414E-41F8-B868-C626E0D3BBFFQ41886918-2A27B8A7-DA67-40FE-AD63-5EC7B54AA913Q42223350-C0A2C37E-0B61-4F4D-91ED-1E3588E66F56Q42364107-D320197F-BE01-490C-A9B0-5439C531ADE3Q43514969-441511C3-7F90-429D-807C-D16D4BA16100Q44539393-02D89147-4D99-4252-B5BD-AAF83DD71F98Q44582650-05834D38-D1C8-4DAA-AC1F-EBCC99691448Q46343725-C8CABB97-5C7F-4CE7-BA17-EF874434D3D9
P2860
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Safety and T cell modulating e ...... entation in multiple sclerosis
@ast
Safety and T cell modulating e ...... entation in multiple sclerosis
@en
Safety and T cell modulating e ...... entation in multiple sclerosis
@nl
type
label
Safety and T cell modulating e ...... entation in multiple sclerosis
@ast
Safety and T cell modulating e ...... entation in multiple sclerosis
@en
Safety and T cell modulating e ...... entation in multiple sclerosis
@nl
prefLabel
Safety and T cell modulating e ...... entation in multiple sclerosis
@ast
Safety and T cell modulating e ...... entation in multiple sclerosis
@en
Safety and T cell modulating e ...... entation in multiple sclerosis
@nl
P2093
P2860
P921
P3181
P1433
P1476
Safety and T cell modulating e ...... entation in multiple sclerosis
@en
P2093
Evelyn Peelen
Jan Damoiseaux
Mariëlle Thewissen
Paul Menheere
Raymond Hupperts
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0015235
P407
P577
2010-12-13T00:00:00Z